NR 507 MIDTERM EXAM ADVANCED
PATHOPHYSIOLOGY Actual Exam
2026/2027 Complete Questions and Verified
Answers 100% Correct Grade A
Chamberlain Pass Guaranteed - A+ Graded
SECTION I: CELLULAR ADAPTATION, INJURY, & DEATH (Questions 1-15)
Question 1 A 55-year-old male with poorly controlled hypertension (BP 180/110 mmHg) for 8
years develops left ventricular hypertrophy without chamber dilation. Which cellular adaptation
is demonstrated, and what is the primary molecular mechanism driving this change?
A) Hyperplasia; activation of growth factor receptors and MAPK signaling
B) Hypertrophy; mechanical stretch activating phospholipase C and protein kinase C pathways
C) Atrophy; ubiquitin-proteasome system activation and protein degradation
D) Metaplasia; stem cell reprogramming via transcription factor activation
Correct Answer: B
Rationale: This patient demonstrates physiologic/pathologic hypertrophy of cardiac myocytes.
The primary stimulus is chronic pressure overload (increased afterload), which causes
mechanical stretch of myocardial fibers. This stretch activates mechanotransduction pathways:
(1) stretch-activated ion channels allow calcium influx; (2) Gq-protein coupled receptors
(angiotensin II, endothelin-1) activate phospholipase C, generating IP3 and DAG; (3) DAG
activates protein kinase C; (4) calcium-calmodulin activates calcineurin, which dephosphorylates
NFAT, allowing nuclear translocation; (5) NFAT and other transcription factors (MEF2, GATA4)
upregulate "fetal gene program" including β-myosin heavy chain and skeletal α-actin. This
increases sarcomere number in parallel (concentric hypertrophy) to normalize wall stress
(Laplace's law: wall stress = pressure × radius / 2 × thickness). Option A is incorrect—cardiac
myocytes are terminally differentiated and cannot undergo hyperplasia (except minor
regeneration). Option C describes the opposite process. Option D involves epithelial cell type
conversion, not myocardial adaptation.
,2
Clinical Correlation: Concentric LV hypertrophy initially compensates for pressure overload
but eventually decompensates due to reduced capillary density, interstitial fibrosis, and diastolic
dysfunction—leading to heart failure with preserved ejection fraction.
Question 2 A 42-year-old female with chronic anovulation and obesity develops endometrial
hyperplasia with atypia. Endometrial biopsy shows glandular proliferation with crowded, back-
to-back glands and nuclear atypia. Which hormonal mechanism drives this adaptation, and what
is the cancer risk?
A) Estrogen unopposed by progesterone; increased risk of endometrial adenocarcinoma
B) Progesterone dominance; protective against endometrial cancer
C) Androgen excess; risk of sarcomatous transformation
D) Cortisol excess; no increased cancer risk
Correct Answer: A
Rationale: This patient demonstrates pathologic hyperplasia (hormonal, with atypia). In
chronic anovulation (polycystic ovary syndrome, obesity with peripheral aromatization of
androgens to estrone in adipose tissue), there is continuous estrogen stimulation without cyclic
progesterone exposure. Estrogen binds nuclear estrogen receptors, activating transcription of
growth-promoting genes (c-myc, cyclin D1) and inhibiting apoptosis via Bcl-2 upregulation.
Normally, progesterone opposes estrogen by: (1) downregulating estrogen receptors; (2)
increasing 17β-hydroxysteroid dehydrogenase type 2 (converts estradiol to weak estrone); (3)
promoting differentiation and apoptosis. Without progesterone opposition, endometrial
proliferation continues. Hyperplasia with atypia carries 30-40% risk of concurrent endometrial
adenocarcinoma and requires hysterectomy or high-dose progestin therapy with close
surveillance. Option B is incorrect—progesterone opposes proliferation. Option C is incorrect—
androgens are aromatized to estrogens but don't directly drive hyperplasia. Option D is
irrelevant.
Clinical Correlation: Endometrial hyperplasia classification (WHO): simple hyperplasia
without atypia (<5% cancer risk), complex hyperplasia without atypia (8% risk), simple
hyperplasia with atypia (25% risk), complex hyperplasia with atypia (30-40% risk).
Question 3 A 68-year-old male with a 40 pack-year smoking history develops squamous
metaplasia of the bronchial epithelium on biopsy. Which statement best describes this adaptation
and its clinical significance?
A) Irreversible change that always progresses to carcinoma
B) Reversible change where columnar epithelium transforms to squamous epithelium due to
chronic irritation; precursor lesion for dysplasia
,3
C) Neoplastic transformation with invasion of basement membrane
D) Apoptotic response to clear damaged cells
Correct Answer: B
Rationale: Metaplasia is a reversible change in which one differentiated cell type is replaced by
another cell type better suited to withstand an environmental stress. In this case, chronic cigarette
smoke exposure (chemical irritation) causes pseudostratified ciliated columnar epithelium →
stratified squamous epithelium. Mechanism: (1) chronic injury depletes stem/progenitor cells;
(2) cytokine signaling (IL-6, TNF-α) and transcription factor reprogramming (NOTCH pathway
downregulation, p63 upregulation) drives transdifferentiation; (3) new squamous epithelium is
more resistant to smoke but lacks mucociliary clearance, predisposing to infection and further
injury. Importantly, metaplasia is reversible if irritant removed but serves as a precursor
lesion—with persistent injury, metaplasia → dysplasia → carcinoma (multistep carcinogenesis).
Option A is incorrect—metaplasia is reversible and doesn't always progress. Option C describes
invasive cancer. Option D describes cell death, not adaptation.
Clinical Correlation: Smoking cessation can reverse bronchial metaplasia, reducing cancer risk.
However, molecular damage (p53 mutations, EGFR mutations) may persist in "field
cancerization," explaining risk of second primary tumors.
Question 4 A patient suffers a myocardial infarction with 45 minutes of coronary occlusion
followed by successful PCI with stent placement. Within minutes of reperfusion, the
myocardium shows accelerated cell death with hypercontracted myofibrils, mitochondrial
calcium overload, and generation of reactive oxygen species. Which mechanism explains this
"reperfusion injury"?
A) Simple continuation of ischemic necrosis without new mechanisms
B) Calcium paradox, pH paradox, and oxygen paradox causing ROS burst, calcium overload,
and opening of mitochondrial permeability transition pore (mPTP)
C) Purely apoptotic cell death via caspase activation
D) Autophagic cell death with lysosomal membrane permeabilization
Correct Answer: B
Rationale: Ischemia-reperfusion injury involves unique mechanisms distinct from ischemia
alone: (1) Calcium paradox: ischemia causes Na+/K+-ATPase failure, leading to Na+
accumulation; reperfusion restores Na+ gradient but Na+/Ca2+ exchanger (reverse mode) drives
massive Ca2+ influx; (2) pH paradox: ischemic acidosis protects mitochondria; rapid pH
correction during reperfusion activates phospholipases and proteases; (3) Oxygen paradox:
sudden oxygen availability allows electron transport chain to donate electrons to partially
reduced coenzyme Q, generating superoxide (•O2-), hydrogen peroxide (H2O2), and hydroxyl
, 4
radical (•OH). These ROS damage lipids (peroxidation), proteins (carbonylation), and DNA.
Critically, calcium overload and oxidative stress trigger opening of the mitochondrial
permeability transition pore (mPTP), causing mitochondrial swelling, rupture, and necrotic
cell death. Option A ignores specific reperfusion mechanisms. Option C is incorrect—
reperfusion primarily causes necrosis, though apoptosis may occur at margins. Option D is not
the primary mechanism.
Clinical Correlation: Strategies to reduce reperfusion injury include ischemic preconditioning,
hypothermia, antioxidant therapies, and cyclosporine (mPTP inhibitor), though clinical
translation has been challenging.
Question 5 A patient with severe carbon monoxide poisoning presents with confusion, cherry-
red skin, and lactic acidosis. CO binds hemoglobin with 240× greater affinity than oxygen.
Which additional mechanism contributes to cellular injury beyond impaired oxygen transport?
A) CO binds cytochrome c oxidase (Complex IV), impairing mitochondrial respiration and
causing oxidative stress
B) CO stimulates erythropoietin production, causing polycythemia
C) CO activates hemoglobin oxygen affinity, increasing oxygen release to tissues
D) CO causes methemoglobinemia, preventing oxygen binding
Correct Answer: A
Rationale: Carbon monoxide toxicity involves multiple mechanisms: (1) Hypoxic hypoxia:
CO binds hemoglobin (carboxyhemoglobin, COHb), shifting oxyhemoglobin dissociation curve
left (decreased O2 release), and reducing oxygen-carrying capacity; (2) Histotoxic hypoxia: CO
binds cytochrome c oxidase (Complex IV) of mitochondrial electron transport chain, impairing
cellular respiration even with normal blood oxygen content; (3) Oxidative stress: CO causes
lipid peroxidation of brain lipids and reperfusion injury when CO is displaced; (4) Nitric oxide
effects: CO displaces NO from hemoglobin, causing vasodilation and hypotension. The cherry-
red color results from bright red carboxyhemoglobin. Option B is incorrect—CO doesn't
stimulate EPO; chronic hypoxia does. Option C is opposite—CO decreases oxygen release (left
shift). Option D describes nitrite or aniline poisoning.
Clinical Correlation: Treatment is 100% oxygen or hyperbaric oxygen to displace CO (half-life
reduced from 4-6 hours to 40-80 minutes). Hyperbaric oxygen is indicated for COHb >25%, loss
of consciousness, or pregnancy.
Question 6 A patient with acetaminophen overdose presents 18 hours after ingestion. Which
sequence of biochemical events leads to hepatic centrilobular necrosis?